Considering the relationship between B1R and TLR4 and the previously described effects of B1R and B2R agonist analogs on the BBB, we investigated whether B1R activation promotes transient BBB opening, which could facilitate drug bioavailability to the brain parenchyma, both with and without a tumor mass. Here, BDKRB1 is linked to neoplasm.